2013
DOI: 10.1007/s12602-013-9151-1
|View full text |Cite
|
Sign up to set email alerts
|

Investigation of the Antimicrobial Activity of Bacillus licheniformis Strains Isolated from Retail Powdered Infant Milk Formulae

Abstract: This study investigated the potential antimicrobial activity of ten Bacillus licheniformis strains isolated from retail infant milk formulae against a range of indicator (Lactococcus lactis, Lactobacillus bulgaricus and Listeria innocua) and clinically relevant (Listeria monocytogenes, Staphylococcus aureus, Streptococcus agalactiae, Salmonella Typhimurium and Escherichia coli) microorganisms. Deferred antagonism assays confirmed that all B. licheniformis isolates show antimicrobial activity against the Gram-p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
12
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(12 citation statements)
references
References 24 publications
0
12
0
Order By: Relevance
“…In addition, B. licheniformis is used for several biotechnological applications for its capacity to produce degrading enzymes such as proteases, lipases, pectate lyases, and polysaccharides [ 59 ]. B. licheniformis has further been shown to exhibit potent antimicrobial activity against indicator strains ( Lactococcus lactis , Lactobacillus bulgaricus and Listeria innocua ) and is clinically relevant ( Listeria monocytogenes , Staphylococcus aureus , Streptococcus agalactiae , Salmonella Typhimurium and Escherichia coli ) bacteria [ 60 ]. B. subtilis is a recognized producer of natural biocontrol agents, having high antifungal activity against Alternaria solani , Botrytis cinerea , Monilia linhartiana 869, Phytophthora cryptogea 759/1 and Rhizoctonia sp., and antibacterial activity against Pseudomonas syringae pv.…”
Section: Resultsmentioning
confidence: 99%
“…In addition, B. licheniformis is used for several biotechnological applications for its capacity to produce degrading enzymes such as proteases, lipases, pectate lyases, and polysaccharides [ 59 ]. B. licheniformis has further been shown to exhibit potent antimicrobial activity against indicator strains ( Lactococcus lactis , Lactobacillus bulgaricus and Listeria innocua ) and is clinically relevant ( Listeria monocytogenes , Staphylococcus aureus , Streptococcus agalactiae , Salmonella Typhimurium and Escherichia coli ) bacteria [ 60 ]. B. subtilis is a recognized producer of natural biocontrol agents, having high antifungal activity against Alternaria solani , Botrytis cinerea , Monilia linhartiana 869, Phytophthora cryptogea 759/1 and Rhizoctonia sp., and antibacterial activity against Pseudomonas syringae pv.…”
Section: Resultsmentioning
confidence: 99%
“…We identified these isolates by 16S rDNA sequencing and revealed that B. licheniformis were more prevalent than other Bacillus species, and were found in raw rice, raw milk, infant fecal samples and infant milk formula. B. licheniformis have been recovered from raw and infant milk powder, and implicated in food poisoning cases [31,32] . B. licheniformis have shown to exhibit pathogenic properties and they may pose a health hazard [33,34] .…”
Section: Discussionmentioning
confidence: 99%
“…Lichenicidin is a lantibiotic that has broad antibacterial activity against Gram-positive organisms (Dischinger et al , 2009). A recent study of isolates of B. licheniformis from powdered infant formula found that the group could be partitioned into lichenicidin producers and non-producers that had greater antibacterial activity (Alvarez-Ordóñez et al , 2014). Group 2 strains contained some low-similarity orthologues to some of the lichenicidin genes found in group 1, specifically LanT, LanM and a LanA-like protein with protein sequence similarities of 48, 33 and 43 %, respectively.…”
mentioning
confidence: 99%